Literature DB >> 10217610

Epitope-specific cytotoxic T lymphocyte induction by minigene DNA immunization.

A Iwasaki1, C S Dela Cruz, A R Young, B H Barber.   

Abstract

Plasmid DNA vaccines encoding full-length antigen often induce both potent antibody and cytotoxic T lymphocyte (CTL) responses. Here, we examine strategies to exclusively elicit epitope-specific CTL responses using DNA constructs expressing a minimal class I MHC-restricted epitope of the nucleoprotein (NP) of influenza virus. The effects of the addition of an ER leader sequence or cytokine combination on minigene-induced CTL responses in vivo were assessed following both delivery by needle injection into skeletal muscle and by gene gun bombardment into skin epidermis. Our data indicate that the leader sequence enhanced the magnitude of the CTL responses, whereas co-injection of the cytokine genes IL-12 and GM-CSF had a minimal effect. An antibody response against NP was not observed in any of the mice receiving the minigene constructs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10217610     DOI: 10.1016/s0264-410x(98)00411-3

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  The signal peptide sequence impacts the immune response elicited by a DNA epitope vaccine.

Authors:  Dimitrios Vatakis; Minnie McMillan
Journal:  Clin Vaccine Immunol       Date:  2011-08-10

2.  Epidermal powder immunization induces both cytotoxic T-lymphocyte and antibody responses to protein antigens of influenza and hepatitis B viruses.

Authors:  D Chen; K F Weis; Q Chu; C Erickson; R Endres; C R Lively; J Osorio; L G Payne
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  DNA sequences encoding CD4+ and CD8+ T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene.

Authors:  A E Fujimura; S S Kinoshita; V L Pereira-Chioccola; M M Rodrigues
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

4.  Prevention of adult T-cell leukemia-like lymphoproliferative disease in rats by adoptively transferred T cells from a donor immunized with human T-cell leukemia virus type 1 Tax-coding DNA vaccine.

Authors:  T Ohashi; S Hanabuchi; H Kato; H Tateno; F Takemura; T Tsukahara; Y Koya; A Hasegawa; T Masuda; M Kannagi
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

5.  Development and characterization of bovine x human hybrid cell lines that efficiently support the replication of both wild-type bovine and human adenoviruses and those with E1 deleted.

Authors:  Alberto L van Olphen; Suresh K Mittal
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

Review 6.  DNA vaccination: using the patient's immune system to overcome cancer.

Authors:  Georg Eschenburg; Alexander Stermann; Robert Preissner; Hellmuth-Alexander Meyer; Holger N Lode
Journal:  Clin Dev Immunol       Date:  2010-12-16

7.  Combination epidermal growth factor receptor variant III peptide-pulsed dendritic cell vaccine with miR-326 results in enhanced killing on EGFRvIII-positive cells.

Authors:  Jianlong Li; Feng Wang; Guangzhi Wang; Ying Sun; Jinquan Cai; Xing Liu; Junhe Zhang; Xiaoyan Lu; Yongli Li; Meng Chen; Lingchao Chen; Chuanlu Jiang
Journal:  Oncotarget       Date:  2017-04-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.